Content about Novartis

February 28, 2010
Manufacturers’ Roulette unlikely to pay a second time

Banking on pandemics is a bit like betting green at the Roulette table. It doesn’t...

February 25, 2010
Colgate-Palmolive adds two members to board of directors

Colgate-Palmolive appointed Helene Gayle, president and CEO of Care USA, and Joseph Jimenez, CEO of...

February 21, 2010
FDA approves Menveo

Novartis has received Food and Drug Administration approval for a vaccine for meningococcal disease, the...

February 18, 2010
Novartis' Tasigna receives priority review from FDA

The Food and Drug Administration will shorten its review time of a Novartis drug under...

February 17, 2010
Decision Resources projects growth in targeted cancer drug market

The market for drugs that fight cancer by focusing on specific molecules, proteins and enzymes...

February 17, 2010
Novartis to change name, repackage Maalox Total Relief

Choosing the wrong liquid Maalox product can have harmful consequences, the Food and Drug Administration...

January 28, 2010
FDA tentatively approves bone cancer generic

The Food and Drug Administration has given tentative approval to a generic version of a...

January 25, 2010
Novartis' Vasella to focus on being chairman, bows out from CEO role

Daniel Vasella will step down as CEO of Novartis to focus on his position as...

January 25, 2010
Sandoz affirms its generic anti-clotting drug will be approved

Sandoz is “confident” that it will win approval for a generic anti-clotting drug, according to...

January 20, 2010
Sandoz launches generic mental disorder treatment

Sandoz has launched a generic version of a drug for schizophrenia and bipolar disorder, the...

January 20, 2010
Teva receives tentative approval for breast cancer drug

The Food and Drug Administration has given tentative approval to Teva Pharmaceutical Industries for its...

January 19, 2010
Alcon criticizes Novartis' acquisition offer

Alcon has seen Novartis’ acquisition offer, and it is not impressed....

January 10, 2010
New P&G initiative may create clash of the OTC titans

This is shaping up to be a Fight Night dream card, with the battle arena...

January 10, 2010
Novartis launches Fanapt

Novartis has launched a new drug for treating schizophrenia in the United States, the Swiss...

January 3, 2010
Novartis announces merger proposal for Alcon

Novartis is looking to purchase the remaining shares in an eye care company....

January 3, 2010
Novartis announces merger proposal for Alcon

With an eye to the future, Novartis brass envisions a growth arena driven by the...

December 3, 2009
Zegerid OTC approved as heartburn remedy

The digestives aisle will be altogether crowded come early 2010, especially with two new proton-pump...

June 28, 2009
Santarus announces Schering-Plough response submission to FDA for OTC Zegerid

There was speculation in January that Schering-Plough’s switch application around the proton-pump inhibitor Zegerid was...

June 11, 2009
Report finds vaccines are major area of growth

The report by Kalorama Information indicating that one of the biggest areas of growth has...

© 2013 Drug Store News. All Rights Reserved.